MediWound (MDWD) Cost of Revenue (2014 - 2026)
MediWound (MDWD) posted quarterly Cost of Revenue of $1.6 million for Q4 2025, down 67.81% year-over-year from $4.9 million in Q4 2024, and down 64.95% quarter-over-quarter from $4.5 million in Q3 2025.
MediWound (MDWD) Cost of Revenue (2014 - 2026) Analysis & Trends
MediWound's Cost of Revenue history runs 12 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Cost of Revenue fell 67.81% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $13.7 million (down 22.08% YoY), while the FY2025 annual figure was $13.7 million, down 22.08% from the prior year.
- Cost of Revenue for Q4 2025 stood at $1.6 million, down from $4.5 million in the prior quarter.
- The five-year high for Cost of Revenue was $4.9 million in Q4 2024, with the low at $1.6 million in Q4 2025.
- The 5-year median for Cost of Revenue is $3.7 million (2021), against an average of $3.7 million.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue surged 46.55% in 2024, then plunged 67.81% in 2025.
- MediWound's Cost of Revenue stood at $3.9 million in 2021, then declined by 12.36% to $3.5 million in 2022, then soared by 33.5% to $4.6 million in 2023, then advanced by 6.88% to $4.9 million in 2024, then slumped by 67.81% to $1.6 million in 2025.
- Business Quant data shows MDWD's Cost of Revenue at $1.6 million in Q4 2025, $4.5 million in Q3 2025, and $4.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 2.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.76 Mn |
| Jun 30, 2026 | 2.76 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 4.53 Mn |
| Sep 30, 2025 | 4.53 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 4.94 Mn |
| Dec 31, 2024 | 4.94 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Dec 31, 2023 | 4.62 Mn |
| Dec 31, 2023 | 4.62 Mn |